Search - tctmd.com

Displaying 61 - 80 of 270

Sort: Relevancy | Date

Presentation TCT 2017

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Presenter: Uzoma Ibebuogu

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Presenter: Christopher B. Granger, Horst Sievert, Pascal Vranckx

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

Presenter: Mitchell W. Krucoff, John C Laschinger, Rachael L. Fleurence

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Presenter: Mitchell W. Krucoff, John C Laschinger, E. Murat Tuzcu

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Presenter: Mitchell W. Krucoff, John C Laschinger

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI With Multivessel Disease How We Treated

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Jacqueline E. Tamis-Holland

October 30, 2017

Presentation TCT 2017

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Stefan K. James

October 30, 2017

Presentation TCT 2017

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Presenter: Sripal Bangalore, Anthony H. Gershlick, Prashant Kaul

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

Advertisement

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Current Guidelines and Recommendations for LAA Closure in Nonvalvular Atrial Fibrillation

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

New U.S. Hypertension Guidelines and Treatment Targets

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Case Resolution: STEMI With Multivessel Disease How We Treated

STEMI/ACS With Multivessel Disease: What Do the US Guidelines and AUC Say?

STEMI/ACS With Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Introduction: STEMI With Multivessel Disease How Should We Treat?

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content